SolaraGrid

SolaraGridSolaraGrid
SolaraGrid

SolaraGrid

SolaraGrid develops AI-powered software for solar energy project development and management.

DR 02021InactiveSan Francisco, United States
Rate

About

SolaraGrid is a startup focused on streamlining the solar energy project lifecycle. Their platform utilizes AI to automate and optimize various stages of solar development, from site assessment and design to permitting and ongoing operations, aiming to accelerate solar adoption.
Frequently asked

What does SolaraGrid do?

SolaraGrid is a startup focused on streamlining the solar energy project lifecycle. Their platform utilizes AI to automate and optimize various stages of solar development, from site assessment and design to permitting and ongoing operations, aiming to accelerate solar adoption.

What is SolaraGrid's revenue?

StartupHub estimates SolaraGrid's annual revenue at $9.9M (range $4.0M to $21.3M, 27% confidence), based on comparable companies in the sector.

What is SolaraGrid's valuation?

StartupHub estimates SolaraGrid's effective valuation at $135.8M (range $87.5M to $210.0M, 11% confidence), based on comparable companies in the sector.

How much funding has SolaraGrid raised?

SolaraGrid has raised a total of $35M in funding.

Where is SolaraGrid headquartered?

SolaraGrid is headquartered in San Francisco, United States.

When was SolaraGrid founded?

SolaraGrid was founded in 2021.

What industry does SolaraGrid operate in?

SolaraGrid operates in Energy & Climate Tech, Solar Energy, AI-Driven Grid Balancing, Sustainability, MLOps, Workflow Automation.

What is SolaraGrid's current status?

SolaraGrid's current operating status is: Inactive.

New entrants in Energy & Climate Tech
Last 90 days
4
New entrants
1.3
Per month
0.3
Per week

An entrant is a company tagged Energy & Climate Tech whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.

Comments

No comments yet. Be the first to share your take.